David J. Mcconkey, Phd, On Non-Invasive Imaging And Monitoring Metastatic Bladder Cancer

David J. McConkey, PhD, on non-invasive imaging and monitoring metastatic bladder cancer

David J. McConkey, PhD, on which drugs have the highest potential to impact bladder cancer treatment

David J. McConkey, PhD, on treating bladder cancer with checkpoint inhibitors

David J. McConkey, PhD, discusses how genomics helps us understand heterogeneity in bladder cancer

David J. McConkey, PhD, on the responses to immunotherapy for varied bladder cancer subtypes

David J. McConkey, PhD, on the influence of genomics for the treatment of bladder cancer subtypes

Navigating Clinical Trials in Bladder Cancer

Johns Hopkins Medicine

Non-invasive Cancer Screening with Capsule Endoscopy

Confocal Imaging: Abnormal mitosis in cancer cells | Protocol Preview

JoVE (Journal of Visualized Experiments)

Dr. Inman Discusses the Biology of Bladder Cancer

The evolving landscape of kidney cancer therapeutics

Dr. David Siegel - Find A Doc

Hackensack Meridian Health

Dr. J. Hermans: Liver and Pancreatic perfusion using Aquilion ONE Vision

Canon Medical Systems Europe

Genomic profiling of muscle invasive bladder cancer

Measuring Response in Non-Muscle Invasive Bladder Cancer

Meet Jerone Kennedy, MD, neurosurgeon

Addressing the unmet needs of immunotherapy in bladder cancer

Understanding how a key antibody targets cancer cells

Canadian Light Source

Michael Levin: Artificial Intelligence and Cancer

Tufts University

A Biodynamic Imaging Platform for Bladder Cancer

Grand Rounds in Urology